Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Niagen Bioscience (NAGE) Revenue (2016 - 2025)

Historic Revenue for Niagen Bioscience (NAGE) over the last 17 years, with Q3 2025 value amounting to $34.0 million.

  • Niagen Bioscience's Revenue rose 3286.16% to $34.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.7 million, marking a year-over-year increase of 3604.42%. This contributed to the annual value of $99.6 million for FY2024, which is 1917.79% up from last year.
  • As of Q3 2025, Niagen Bioscience's Revenue stood at $34.0 million, which was up 3286.16% from $31.1 million recorded in Q2 2025.
  • Niagen Bioscience's Revenue's 5-year high stood at $34.0 million during Q3 2025, with a 5-year trough of $14.7 million in Q1 2021.
  • Moreover, its 5-year median value for Revenue was $21.0 million (2022), whereas its average is $22.0 million.
  • As far as peak fluctuations go, Niagen Bioscience's Revenue plummeted by 546.36% in 2022, and later skyrocketed by 3759.31% in 2025.
  • Quarter analysis of 5 years shows Niagen Bioscience's Revenue stood at $17.8 million in 2021, then grew by 18.23% to $21.0 million in 2022, then increased by 0.95% to $21.2 million in 2023, then surged by 37.41% to $29.1 million in 2024, then increased by 16.69% to $34.0 million in 2025.
  • Its last three reported values are $34.0 million in Q3 2025, $31.1 million for Q2 2025, and $30.5 million during Q1 2025.